Presentation5_Valsartan attenuates LPS-induced ALI by modulating NF-κB and MAPK pathways.PPTX by Mi Zhou (9884)

“…<p>Background: Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is a common respiratory disease characterized by persistent hypoxemia and an uncontrolled inflammatory response. …”

DataSheet_1_Transcriptome analysis reveals that auxin promotes strigolactone-induced adventitious root growth in the hypocotyl of melon seedlings.pdf by Jingrui Li (1546318)

“…Compared to that in the control, the ABA content decreased by 10.30%–11.83% in the GR24 treatment group and decreased by 18.78%-24.00% in the GR24+IAA treatment group at 6–10 days.…”

DataSheet1_Valsartan attenuates LPS-induced ALI by modulating NF-κB and MAPK pathways.ZIP by Mi Zhou (9884)

“…<p>Background: Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is a common respiratory disease characterized by persistent hypoxemia and an uncontrolled inflammatory response. …”

DataSheet3_Valsartan attenuates LPS-induced ALI by modulating NF-κB and MAPK pathways.ZIP by Mi Zhou (9884)

“…<p>Background: Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is a common respiratory disease characterized by persistent hypoxemia and an uncontrolled inflammatory response. …”

Presentation4_Valsartan attenuates LPS-induced ALI by modulating NF-κB and MAPK pathways.PPTX by Mi Zhou (9884)

“…<p>Background: Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is a common respiratory disease characterized by persistent hypoxemia and an uncontrolled inflammatory response. …”

Image3_Valsartan attenuates LPS-induced ALI by modulating NF-κB and MAPK pathways.TIF by Mi Zhou (9884)

“…<p>Background: Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is a common respiratory disease characterized by persistent hypoxemia and an uncontrolled inflammatory response. …”

Presentation2_Valsartan attenuates LPS-induced ALI by modulating NF-κB and MAPK pathways.PPTX by Mi Zhou (9884)

“…<p>Background: Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is a common respiratory disease characterized by persistent hypoxemia and an uncontrolled inflammatory response. …”

Image10_Valsartan attenuates LPS-induced ALI by modulating NF-κB and MAPK pathways.TIF by Mi Zhou (9884)

“…<p>Background: Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is a common respiratory disease characterized by persistent hypoxemia and an uncontrolled inflammatory response. …”

Image12_Valsartan attenuates LPS-induced ALI by modulating NF-κB and MAPK pathways.TIF by Mi Zhou (9884)

“…<p>Background: Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is a common respiratory disease characterized by persistent hypoxemia and an uncontrolled inflammatory response. …”

DataSheet11_Valsartan attenuates LPS-induced ALI by modulating NF-κB and MAPK pathways.ZIP by Mi Zhou (9884)

“…<p>Background: Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is a common respiratory disease characterized by persistent hypoxemia and an uncontrolled inflammatory response. …”

Table2_Valsartan attenuates LPS-induced ALI by modulating NF-κB and MAPK pathways.XLSX by Mi Zhou (9884)

“…<p>Background: Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is a common respiratory disease characterized by persistent hypoxemia and an uncontrolled inflammatory response. …”

Image13_Valsartan attenuates LPS-induced ALI by modulating NF-κB and MAPK pathways.TIF by Mi Zhou (9884)

“…<p>Background: Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is a common respiratory disease characterized by persistent hypoxemia and an uncontrolled inflammatory response. …”

Image4_Valsartan attenuates LPS-induced ALI by modulating NF-κB and MAPK pathways.TIF by Mi Zhou (9884)

“…<p>Background: Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is a common respiratory disease characterized by persistent hypoxemia and an uncontrolled inflammatory response. …”

Image2_Valsartan attenuates LPS-induced ALI by modulating NF-κB and MAPK pathways.TIF by Mi Zhou (9884)

“…<p>Background: Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is a common respiratory disease characterized by persistent hypoxemia and an uncontrolled inflammatory response. …”

Image8_Valsartan attenuates LPS-induced ALI by modulating NF-κB and MAPK pathways.TIF by Mi Zhou (9884)

“…<p>Background: Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is a common respiratory disease characterized by persistent hypoxemia and an uncontrolled inflammatory response. …”

Image9_Valsartan attenuates LPS-induced ALI by modulating NF-κB and MAPK pathways.TIF by Mi Zhou (9884)

“…<p>Background: Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is a common respiratory disease characterized by persistent hypoxemia and an uncontrolled inflammatory response. …”

Image6_Valsartan attenuates LPS-induced ALI by modulating NF-κB and MAPK pathways.TIF by Mi Zhou (9884)

“…<p>Background: Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is a common respiratory disease characterized by persistent hypoxemia and an uncontrolled inflammatory response. …”

Image11_Valsartan attenuates LPS-induced ALI by modulating NF-κB and MAPK pathways.TIF by Mi Zhou (9884)

“…<p>Background: Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is a common respiratory disease characterized by persistent hypoxemia and an uncontrolled inflammatory response. …”

Protospacer and 5’-triphosphate determine the intensity of the gRNA-mediated IFNβ response. by Beeke Wienert (5518496)

“…<p>(A) qRT-PCR analysis of <i>IFNB1</i> transcript levels in HEK293 cells transfected with equal amounts of gRNAs containing different 20-nucleotide protospacers. gRNAs were ordered by decreasing levels of <i>IFNB1</i> activation. gRNA1 refers to the gRNA that has been used in all previous experiments. …”

Table_1_Causal role of immune cells in generalized anxiety disorder: Mendelian randomization study.xlsx by Zhen Ma (281909)

“…GAD also exerted a causal effect on CD27 on IgD-CD38br (β=-0.155,95%CI=0.78~0.94,P=0.002), CD20-%B cell (β= -0.105,95% CI=0.77~0.94, P=0.002), IgD-CD38br%lymphocyte(β=-0.305, 95%CI=0.79~0.95, P=0.002), FSC-A level on granulocytes (β=0.200, 95%CI=0.75~0.91, P=8.35×10⁻⁵), and CD4RA on TD CD4+(β=-0.150, 95% CI=0.82~1.02, P=0.099). …”